Federated Hermes, Inc. PROGENICS PHARMACEUTICALS IN Transaction History

Federated Hermes, Inc.

  • $43 Billion
  • Q4 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
N/A
-1,809 Closed
0 $0
Q1 2020

May 13, 2020
BUY
N/A
104 Added 6.1%
1,809 $7,000
Q4 2019

Feb 14, 2020
SELL
N/A
-113 Reduced 6.22%
1,705 $9,000
Q3 2019

Nov 14, 2019
BUY
N/A
1,818 New
1,818 $9,000
Q1 2019

May 10, 2019
SELL
N/A
-3,451,447 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
N/A
-2,967,153 Reduced 46.23%
3,451,447 $0
Q3 2018

Nov 13, 2018
SELL
N/A
-577,455 Reduced 8.25%
6,418,600 $40.2 Million
Q2 2018

Aug 10, 2018
SELL
N/A
-3,191,708 Reduced 31.33%
6,996,055 $56.2 Million
Q4 2017

Feb 14, 2018
SELL
N/A
-429,700 Reduced 4.05%
10,187,763 $0
Q3 2017

Nov 13, 2017
BUY
N/A
10,617,463
10,617,463 $78.1 Million
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email